Pancragen (20 mg)

Pancragen, a naturally existing tetrapeptide bioregulator, primarily targets the pancreas, as its name suggests. It’s important not to mistake it for the DNA-centric PancraGEN test. Pancragen has demonstrated capabilities in managing blood sugar levels, enhancing the endocrine function of the pancreas, controlling melatonin expression, and diminishing the occurrence and severity of metabolic syndrome. It has been subject to investigation and holds promise in addressing both diabetes and the metabolic consequences associated with aging. In a way, Pancragen could be considered an anti-aging peptide specifically benefiting the pancreas.